Get the latest news, insights, and market updates on CL (Colgate-Palmolive Company). Explore the news page 12 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Trump’s Venezuela oil push unlikely to move needle on prices, analyst warns
Investing.com -- U.S. President Donald Trump’s pledge to unlock more Venezuelan barrels after the capture of President Nicolas Maduro has stirred up geopolitical tensions but is unlikely to dent an already imbalanced, oversupplied oil market, keeping prices under pressure, Kepler Cheuvreux’s Bertrand Hodée warned in a recent note. Jan 5, 2026 - $CL
Is Colgate-Palmolive’s Earnings Beat Streak Reshaping Analyst Expectations And Its Investment Narrative (CL)?
Colgate-Palmolive recently approached its fourth-quarter earnings release, with analysts expecting a single-digit improvement in its bottom line after four consecutive earnings beats. This track record, combined with a consensus “Moderate Buy” rating, highlights how analyst expectations and confidence can shape attention ahead of results. We’ll now examine how Colgate-Palmolive’s consistent earnings outperformance shapes its broader investment narrative amid upcoming quarterly results... Jan 5, 2026 - $CL
Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook
Colgate-Palmolive Company (NYSE:CL) is included among the 14 Best Dividend Aristocrats to Invest in Heading into 2026. On December 19, BofA raised its price target on Colgate-Palmolive Company (NYSE:CL) to $90 from $88 and kept a Buy rating. Looking ahead to 2026, the firm said the biggest open question for consumer staples is still consumption […] Dec 30, 2025 - $CL
BofA warns BP faces downside despite $6 bln Castrol proceeds
Investing.com -- BP said last week it has agreed to sell a 65% stake in its Castrol lubricants business to infrastructure investor Stonepeak at an enterprise value of $10 billion, as the energy major steps up asset sales to reduce debt. Dec 29, 2025 - $CL
2 Reasons to Like CL and 1 to Stay Skeptical
Over the past six months, Colgate-Palmolive’s shares (currently trading at $79.74) have posted a disappointing 12.3% loss, well below the S&P 500’s 11.7% gain. This might have investors contemplating their next move. Dec 29, 2025 - $CL
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.